31.94
Genmab Adr Aktie (GMAB) Neueste Nachrichten
Analysts Offer Insights on Healthcare Companies: Genmab (GMAB), Definitive Healthcare Corp (DH) and Atai Beckley N.V. (ATAI) - The Globe and Mail
Genmab A/S Sponsored ADR (NASDAQ:GMAB) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Legacy Wealth Asset Management LLC Grows Stake in Genmab A/S Sponsored ADR $GMAB - MarketBeat
Genmab A/S Q2 Earnings Call Highlights - Yahoo Finance
Quantinno Capital Management LP Grows Position in Genmab A/S Sponsored ADR $GMAB - MarketBeat
Genmab (GMAB) Posts Perfect Technical and Setup Scores in Breakout Setup - ChartMill
Sanctuary Advisors LLC Decreases Holdings in Genmab A/S Sponsored ADR $GMAB - MarketBeat
Genmab A/S Sponsored ADR $GMAB Shares Bought by Renaissance Technologies LLC - MarketBeat
Genmab and AbbVie Provide Clarification on Phase 3 EPCORE® DLBCL-1 Trial Evaluating Epcoritamab (DuoBody®-CD3xCD20) in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL) - GlobeNewswire Inc.
Genmab/AbbVie lymphoma trial meets main goal, analyst eyes bigger market opportunity - MSN
Barometer Capital Management Inc. Boosts Holdings in Genmab A/S Sponsored ADR $GMAB - MarketBeat
ETFs Investing in Genmab A/S Sponsored ADR Stocks - TradingView
What Makes Genmab A/S Sponsored ADR (GMAB) a Strong Momentum Stock: Buy Now? - MSN
Genmab A/S Sponsored ADR (NASDAQ:GMAB) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Diversify Wealth Management LLC Takes $1.22 Million Position in Genmab A/S Sponsored ADR $GMAB - marketbeat.com
EU Approves Expanded Use of ABBV's Tepkinly in Follicular Lymphoma - TradingView
GMABGenmab ADR Earnings - Finviz
Amazon To Rally Over 29%? Here Are 10 Top Analyst Forecasts For Thursday - benzinga.com
Genmab (GMAB) Shows Modest Gains Amid Consolidation: Support and Resistance Levels in FocusFair Value Gap - dars.gov.et
Genmab/AbbVie Lymphoma Trial Meets Main Goal, Analyst Eyes Bigger Market Opportunity - Sahm
Genmab opens the weekend with a clear strategy focus, shares hold their biotech range - Ad-hoc-news.de
Genmab A/S Sponsored ADR Actuals & Estimates (NASDAQ:GMAB) - TradingView
GE91 Forecast — Price Target — Prediction for 2027 - TradingView
GMAB1/N Forecast — Price Target — Prediction for 2027 - TradingView
GMAB News | GENMAB A/S -SP ADR (NASDAQ:GMAB) - ChartMill
Genmab A/S stock (DK0010272202): Copenhagen shares weaken as investors weigh outlook after updated A - AD HOC NEWS
GMAB Q1 2026 Earnings: EPS Misses Estimates by Over 40% as Stock DeclinesQuarterly Earnings Report - The Legal Advocate
Analysts Offer Insights on Healthcare Companies: Roivant Sciences (ROIV), Crescent Biopharma (CBIO) and Genmab (GMAB) - The Globe and Mail
GMAB Stock Price, Quote & Chart | GENMAB A/S -SP ADR (NASDAQ:GMAB) - ChartMill
GMAB vs. ACAD: Which Stock Is the Better Value Option? - MSN
Genmab A/S stock (DK0010272202): earnings momentum and oncology pipeline keep investors watching - AD HOC NEWS
Genmab stock (DK0010272202): Analyst sentiment shifts as earnings forecasts decline - AD HOC NEWS
Genmab Earnings: Strong Patient Uptake and Diverse Late-Stage Pipeline Support Positive Outlook - Morningstar
Genmab A/S Q1 Earnings Call Highlights - finance.yahoo.com
Oppenheimer Asset Management Inc. Acquires 48,894 Shares of Genmab A/S Sponsored ADR $GMAB - MarketBeat
Pictet Asset Management Holding SA Takes $33.84 Million Position in Genmab A/S Sponsored ADR $GMAB - MarketBeat
Genmab ADR shows improved relative strength; still shy of benchmark - MSN
BioNTech (BNTX) surges 6.1%: Is this an indication of further gains? - MSN
BioNTech (BNTX) Surges 6.1%: Is This an Indication of Further Gains? - Yahoo Finance
Bispecific Antibody Drug Conjugates Market Landscape Report 2026: A $2 Billion Opportunity by 2030 with the 1st Approved BsADC by 2028 - GlobeNewswire Inc.
Bispecific Antibody Market Landscape Report 2026: A Potential $60 Opportunity by 2031Insight on More than 550 Clinical Trials - GlobeNewswire Inc.
Genmab A/S (NASDAQ:GMAB) Sees Large Volume IncreaseTime to Buy? - MarketBeat
Genmab A/S Sponsored ADR $GMAB Shares Bought by Assetmark Inc. - MarketBeat
Corbus Offers Upside Despite Post-FDA Update, Analyst Highlights Competitive Edge - Sahm
827,217 Shares in Genmab A/S Sponsored ADR $GMAB Bought by Perpetual Ltd - marketbeat.com
JPMorgan Chase & Co. Decreases Position in Genmab A/S Sponsored ADR $GMAB - MarketBeat
Arrowpoint Investment Partners Singapore Pte. Ltd. Takes Position in Genmab A/S Sponsored ADR $GMAB - MarketBeat
Genmab AS (ADR) (US3723032062.SG) Q1 FY2025 earnings call transcript - Yahoo Finance
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):